Capillary-induced Homogenization Of Matrix In Paper: A Powerful Approach For The Quantification Of Active Pharmaceutical Ingredients Using Mass Spectrometry Imaging by de Menezes et al.
1Scientific RepoRts | 6:29970 | DOI: 10.1038/srep29970
www.nature.com/scientificreports
Capillary-induced Homogenization 
of Matrix in Paper: A Powerful 
Approach for the Quantification of 
Active Pharmaceutical Ingredients 
Using Mass Spectrometry Imaging
Maico de Menezes, Diogo Noin de Oliveira & Rodrigo Ramos Catharino
Herein we present a novel approach for the quantification of active pharmaceutical ingredients (APIs) 
using mass spectrometry imaging. This strategy uses a filter paper previously “eluted” with a MALDI 
matrix solution as a support for analyte application. Samples are submitted to mass spectrometry 
imaging (MSI) and quantification through characteristic fingerprints is ultimately performed. Results 
for the content of rosuvastatin from a known formulation are comparable to those obtained with a 
validated HPLC method.
Quantitative analysis of Active Pharmaceutical Ingredients (APIs) plays a major role on the routine of pharma-
ceutical companies, for reasons that range from quality control1,2 and pharmaceutical development3 to compli-
ance with regulatory demands4. Chromatographic approaches, such as HPLC and GC, are widely employed in 
these environments, and are aimed at controlling both APIs5, residual solvents6 and other related substances/
impurities7 in tablets, capsules and a wide array of other dosage forms8. The main issue with the use of chroma-
tography is mostly derived from the residues of solvents that are generated from the analyses; growing trends in 
green chemistry now lean toward the minimization of waste arising from routine analyses9.
Mass spectrometry (MS) has been increasingly employed as a powerful analytical tool that can be successfully 
implemented in pharmaceutical analyses10 for its great specificity in providing reliable results regarding structure 
information of target molecules in complex mixtures. Within the scope of MS, several important advances were 
developed in the last couple of decades, noticeably the use of soft ionization techniques such as MALDI coupled 
with mass spectrometry imaging (MSI) features11, to obtain valuable information on the spatial distribution of 
active ingredients directly from the tablet12. Other studies broadened this view, by showing that the quantification 
of degradation products of APIs is also possible directly in the tablet itself, with remarkable results, even when 
compared to standard methodologies such as HPLC13.
Analytical approaches based on MS that deal with complex samples usually rely on chromatography for 
cleaning and retaining undesired compounds, preventing them from entering the instrument. In this sense, 
sample-eluted paper has already been used as an ingenious and suitable support for samples submitted to MS 
analyses, with ionization methods similar to ESI – the paper spray approach14,15, with applications in biological 
samples16 and quantitative analyses17, rendering a successful technique that has since been developed to provide 
even better results. Following a similar trend, this contribution presents a novel approach for the quantification 
of active pharmaceutical ingredients (APIs) using mass spectrometry imaging. This strategy uses a filter paper 
previously “eluted” with a MALDI matrix solution that will serve as a “readily-ionizable”, homogenous support 
for further analyte application and analysis. The paper strips are submitted to MSI, followed by quantification 
through chemical images of the selective drug signal is ultimately performed, following the principles described 
in earlier contributions18,19.
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Experimental Section
Rosuvastatin standard stock solution. A concentrated rosuvastatin standard stock solution was 
employed for achieving all subsequent dilutions used in the calibration curve, made up with 98.5 mg of rosuvas-
tatin (96.1% of purity) in 20 mL of methanol:acetonitrile (1:1), to achieve a final concentration of 4.733 mg.mL−1.
Sample preparation. A piece of 80 g/m2 quantitative filter paper (nominal ash content: 90 μ g) with 6-μ m 
pore size (Nalgon, Brazil) was cut into 2.5 × 7.5 cm strips and previously tested to check if any interferences would 
appear on the selective ion region (data not shown). A solution of α -cyano-4-hydroxycinnamic acid (CHCA) 
MALDI matrix was prepared in methanol/acetonitrile (50:50) to a final concentration of 25 mg/mL. The filter 
paper strips were introduced in a glass chamber containing the matrix solution at the bottom and were left to 
elute completely. Samples from twenty (20) macerated commercial 10-mg generic rosuvastatin tablets of a sin-
gle manufacturer were diluted in methanol/acetonitrile (50:50) and used for measuring rosuvastatin content. 
Rosuvastatin standard (Teva API India Limited, India) was diluted in the same solvent system, in different con-
centrations (0.12, 0.24, 0.36, 0.48 and 0.6 mg.mL−1, i.e. 25. 50, 75. 100 and 125%, respectively, as described in the 
previous subsection above) to build a calibration curve. 2 μ L of the final sample solutions were spotted onto the 
filter paper strips, in triplicates, and sent for mass spectrometry analysis after solvent drying. A brief scheme of 
the workflow used in the experiments may be found in Fig. 1.
Mass spectrometry. Experiments were conducted in an LTQ-XL MALDI instrument (Thermo Scientific, 
San Jose CA) equipped with imaging feature. Typical operating conditions were set as follows: 10 mJ of laser 
power, 60 μ m of raster step size, sample size of 600 × 600 μ m, three laser shots per step and collision induced 
dissociation energy set at 40 units, using helium as the buffer gas for MS/MS measurements. Survey scan analyses 
were performed at the m/z range of 380–600, in the positive ion mode.
Data workup. Spectral and MS/MS results were analyzed using Mass Frontier software (v. 6.0, Thermo 
Scientific, San Jose, CA). MSI data were treated using ImageQuest software (Thermo Scientific, San Jose, CA); 
quantification using MSI was carried out according to de Oliveira et al.20, where the area (pixels) of the obtained 
chemical images in grayscale were analyzed using the ImageJ software (National Institutes of Health – Open 
Source). This software provided arbitrary values regarding pixel intensity: a lighter color in the scale meant less 
amount of the substance, while a darker color meant a higher amount, much like an HPLC approach, where larger 
peaks signify larger amounts of the analyte. No data normalization was performed. The obtained arbitrary values 
provided by ImageJ were then used to plot the analytical curve.
HPLC. Chromatographic analyses used for comparison in method validation were carried out in a LaChrom 
Elite, Merck Hitachi HPLC instrument equipped with a Purospher® STAR RP18e 150 × 4.6 mm 5-μ m column. 
Mobile phase was comprised of a 0.05 M formic acid solution and acetonitrile (65:35). Other parameters were as 
follows: flow rate set at 2.0 mL.min−1; injection volume of 10 μ L; oven temperature of 35 °C and DAD detector 
set at λ = 250 nm. Samples were diluted according to the method described above, with a further filtration step 
through a 0.45-μ m PVDF filter. Rosuvastatin retention time was observed at 8.3 min. All validation calculations 
were performed using the software Validation Manager (version 3.40O, VWR International, Germany).
Results and Discussion
Two main validation parameters were tested to check the power and feasibility of this application: selectivity and 
linearity. The first was verified through characterization by tandem mass spectrometry (MS/MS; high-resolution 
figure with structure assignments can be found in supporting information). Figure 1 presents the general work-
flow of the analytical approach, while Fig. 2 portrays the fragmentation profile of rosuvastatin, with structures 
assigned to each product ion found, as well as the comparison between linearity curves of MSI and a validated 
HPLC methodology used for routine quality control.
Linearity check was performed through the establishment of a calibration curve using MSI. After filter paper 
preparation, extracted 10-mg rosuvastatin tablets obtained from a local manufacturer were used to build a 5-point 
curve, with concentrations that ranged from 0.12 to 0.6 mg.mL−1. Rosuvastatin content was measured using the 
calibration curve; Table 1 organizes results from the calibration curve, along with the relative standard deviation 
(RSD, %); and Table 2 observed content for the commercial rosuvastatin tablet. Since RSD values for content were 
found under the recommended threshold of 2% 21, the MSI strategy may be considered equivalent to HPLC regard-
ing the linearity parameter (HPLC content value for a validated method: 99.8%, RSD 0.804%, data not shown). 
Estimates of limit of detection (LoD) and limit of quantification (LoQ) were calculated using Validation Manager 
Software (version 3.40O, VWR International, Germany), and compared to those obtained with HPLC, as seen in 
Table 1. The calibration curve presented a calculated confidence level of 97.50; values of LoQ were at 0.252 mg.mL−1 
and LoD < 0.01 mg.mL−1, calculated according to Huber21. The observed recovery in MALDI-MSI for rosuvas-
tatin extraction at 100% (0.47 mg.mL−1) is 0.465 mg.mL−1 (98.23%). Hence, the obtained results for linearity 
were deemed validated according to the specifications, as they were within the range for quality control of the 
finished product (content must be within the range of 90–110%; HPLC: Recovery = 99.8%; LoQ = 4.47 μ g.mL−1 
and LoD = 1.47 μ g.mL−1, data not shown).
Using matrix-impregnated filter paper as a support for ionization in MALDI-MSI presented sufficient evi-
dence to be considered an effective method to perform simple and effective quantitative assessment of APIs. 
The strategy of eluting the paper with a matrix solution prior to sample incorporation eliminates potential prob-
lems with homogeneity, which is a considerable drawback in MALDI analyses. Figure 3 illustrates the compar-
ison between a regular filter paper and after impregnation with matrix. It is possible to notice the homogenous 
dispersion of matrix across the paper fibers, which enhances the ionization potential of molecules deposited 
onto the paper slide. Several advantages may be therefore inferred from this approach; the use of filter paper, an 
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inexpensive laboratory item, has a standardized grammage and pore size, as well as a very small and controlled 
amount of impurities (denominated as “ash content”), which are very desirable characteristics for an analytical 
support. Furthermore, using elution to saturate the paper with matrix is a cost-effective strategy, using very little 
amounts of solvent and rendering a very homogenous base for ionization, which is evidenced by the linearity 
observed in the experiments, in addition to an environmental-friendly approach, with little solvent residues gen-
erated in the process. Moreover, although HPLC is accurate and precise enough, MALDI-MSI offers a wide range 
of features to assist in characterization and control of organic molecules that are suitable for API control; MS/MS 
Figure 1. Detailed workflow of the experiments used to carry out MALDI-MSI quantification of 
rosuvastatin. 
www.nature.com/scientificreports/
4Scientific RepoRts | 6:29970 | DOI: 10.1038/srep29970
Figure 2. (A) Typical chromatogram; (B) linearity profile of HPLC; (C) typical MS/MS of rosuvastatin and  
(D) linearity profile for MALDI-MSI.
Sample volume (mL) Final volume (mL) Concentration (mg.mL−1) Area (arb units) RSD (%)
0.25 10.00 0.11832 61282934 5.999
0.50 10.00 0.23665 86460116 1.470
0.75 10.00 0.35497 95403564 1.176
1.00 10.00 0.47329 114391013 2.573
1.25 10.00 0.59162 138185037 1.307
Table 1.  MALDI-MSI calibration curve data.
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(tandem MS) emerges as a better and more reliable alternative to ensure method specificity, enhancing the 
method selectivity. The major limitation of the method, in comparison with HPLC, is in terms of precision and 
accuracy. This may be explained by the characteristics of the ionization, intrinsic to the method; MALDI uses a 
pulsed laser to ionize molecules, and the brief interruption in ion formation and, consequently, detection, may 
directly influence in quantitative results, causing undesired fluctuations and, sometimes, higher RSD values when 
compared to a conventional approach. However, our experiments evidenced that this phenomenon has very little 
influence over the results, providing values that are within the acceptable ranges across all analyzed concentra-
tions, in a very straightforward and timely fashion.
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